Understanding Skin Cancer Stages: From Stage 0 to Stage 4

It’s one of those medical terms that sounds definitive, like it should tell you exactly what happens next.

In reality, staging is a way of describing where the cancer is, how far it has grown, and whether it has spread. It helps your team plan treatment and talk to each other clearly. It’s useful, and it’s not a prophecy.

One important thing you should know. “Skin cancer” is not just one disease. So the staging system is not identical across all types.

What does “staging” actually mean?

Most cancer staging runs from Stage 0 to Stage 4.

• Lower stages (0 to 2) usually mean the cancer is confined to the skin or close to where it started.
• Stage 3 often means the cancer is more locally advanced and or has reached nearby lymph nodes.
• Stage 4 means it has spread to distant parts of the body.

Doctors, mainly oncology specialists, commonly use something called TNM staging to get there:

• T for Tumour. How large it is, and how deep it has grown into the skin and nearby tissues.
• N for Nodes. Whether it has spread to nearby lymph nodes.
• M for Metastasis. Whether it has spread to distant organs.

Not every skin cancer uses TNM in exactly the same way. But the logic stays pretty consistent.

Why staging varies by skin cancer type

There are two broad groups that people usually mean when they say “skin cancer”:

1. Non-melanoma skin cancers, mainly:

• Basal cell carcinoma (BCC)
• Squamous cell carcinoma (SCC)

2. Melanoma

Basal cell carcinoma is extremely common and, in most cases, behaves in a very local way. It can be destructive where it sits, but it rarely spreads to lymph nodes or beyond. Because of that, BCC is not always formally staged unless it is unusually large, deeply invasive, recurrent, or in a higher-risk location.

SCC is also often treatable when caught early, but it has a higher chance of spreading than BCC. Staging is more commonly used for SCC.

Melanoma is the one most people have heard of because it is more likely to spread if it is not caught early. Staging is more detailed, and it tends to focus heavily on depth, ulceration (whether the surface skin over the tumour is broken), lymph nodes, and distant spread.

So when you read “Stage 2”, you always need to ask: “Stage 2 of what type?”

Stage 0 (carcinoma in situ)

Stage 0 means the cancer cells are only in the very top layer of the skin. They have not invaded deeper layers.

You might hear this described as “in situ”, which basically means “in its original place”.

• In non-melanoma skin cancer, Stage 0 is often associated with SCC in situ, sometimes called Bowen’s disease.
• In melanoma, melanoma in situ means the abnormal pigment cells are confined to the surface layer.

In most cases, Stage 0 is highly treatable because it has not had the chance to spread deeper.

Stage 1 (early invasive, localised)

Stage 1 generally means the cancer has started to grow into deeper layers of skin, but it is still localised. No lymph node spread. No distant spread.

For non-melanoma cancers like SCC, Stage 1 often relates to a relatively small tumour that is limited to the skin and does not show signs of spread.

For melanoma, Stage 1 is still early, but it is usually defined by features like tumour thickness and whether there is ulceration. In simple terms, thinner lesions and those without ulceration tend to sit in earlier stages.

If you are reading this because you have been told “Stage 1”, it is reasonable to ask your clinician what factors led to that staging. It helps you understand what they are responding to.

Stage 2 (larger tumour, still no nodes)

Stage 2 typically means the tumour is larger and/or has features that suggest it is higher risk. But it is still considered local, with no confirmed lymph node involvement and no distant spread.

For SCC, Stage 2 can be used when the tumour is bigger, or when there are additional features that increase risk. These features are assessed by pathology and clinical examination, and they are part of why two tumours of similar size can be managed differently.

For melanoma, Stage 2 usually means the tumour is thicker and or ulcerated, but there is still no evidence it has reached the lymph nodes or other organs.

This is often the stage where people get told they might need additional checks, not because something terrible is assumed, but because the risk profile is higher than Stage 1.

Stage 3 (locally advanced and/or regional spread)

Stage 3 generally means one of two things:

1. The tumour has become more locally advanced, growing into deeper tissues or nearby structures, and or
2. There is evidence that it has spread to nearby lymph nodes.

For non-melanoma cancers like SCC, Stage 3 can involve deeper invasion and or regional lymph node involvement. The details depend on tumour size, depth, and what is found in the lymph nodes.

For melanoma, Stage 3 most commonly means the cancer has spread to nearby lymph nodes and or small tumour deposits close to where the melanoma started.

This is the stage where the word “spread” tends to enter the conversation, which is understandably unsettling. But it is still often managed with curative intent, depending on the exact situation.

Stage 4 (advanced disease)

Stage 4 means the cancer has spread beyond the local area and regional lymph nodes to distant sites in the body.

For melanoma, Stage 4 typically refers to distant metastasis, which can involve organs such as the lungs, liver, bones, brain, or elsewhere.

For non-melanoma skin cancers, Stage 4 is less common, but it can happen, particularly with more aggressive SCC or neglected, deeply invasive disease. Stage 4 can include distant spread or significant spread through lymph nodes with extensive involvement.

While Stage 4 sounds final, it is not. It does usually mean treatment becomes more complex and specialist-led, and goals can vary depending on the situation. But there are meaningful treatments available, and the landscape has changed a lot over recent years, particularly for melanoma.

How doctors confirm the stage

Staging is not guesswork. It is built from a combination of clinical assessment and test results.

Common components include:

• Skin examination and assessment of the lesion and surrounding area.
• Biopsy results provide the key details about cancer type and risk features.
• Lymph node examination, which is done by feeling the common drainage areas.
• Imaging, when appropriate. This may include scans such as CT and or PET in higher-risk or more advanced cases.
• In melanoma and other high-risk scenarios, additional tests may be considered to evaluate lymph node involvement.

Not everyone needs every test. If your cancer is clearly local and low risk, your staging work-up may be relatively simple.

What staging means for treatment

Treatment depends on cancer type, location, size, depth, your general health, and the pathology details. But broadly:

• Stages 0 to 2 are often treated with procedures aimed at removing the cancer locally. That might be surgical excision, and in selected cases, specialised techniques designed to preserve tissue in delicate areas.
• Stage 3 often involves a wider plan, which may include treatment of lymph nodes and additional therapies depending on risk.
• Stage 4 typically involves systemic treatment and care from a specialist multidisciplinary team. The goal might be long-term control, symptom management, or, in some cases, remission. It varies.

If you have a stage and you are wondering what it implies for you, the most helpful question is usually: “What is the aim of treatment in my case, and what are the next steps to confirm the plan?”

Stage vs grade

People often mix these up.

• Stage describes where the cancer is and how far it has spread.
• Grade describes how abnormal the cancer cells look under the microscope and can hint at how aggressively they might behave.

For some non-melanoma skin cancers, grading can be part of assessing risk and guiding treatment decisions. Melanoma conversations tend to focus more on thickness, ulceration, and spread rather than “grade” in the same way.

When to seek medical advice

If you have a skin lesion that is changing, bleeding, crusting, not healing, or simply does not feel right, these can be symptoms of skin cancer, and it is worth getting it checked.

Likewise, a lump that is growing or a mole that changes in shape, colour, size, or becomes symptomatic needs assessment. You do not need to diagnose it yourself. That is the whole point of seeing an oncology specialist.

Early assessment is not about being dramatic. It is just sensible.

What does this all mean?

Staging helps clinicians speak the same language. It guides decisions. It can also make everything feel very stark.

But you are not a stage number.

If you have been given a stage and you are anxious about what it means, we can usually make things clearer by answering three questions: what type of skin cancer is it, what evidence was used to stage it, and what is the aim of treatment?

That is where the useful information lives.

About Dr James Wilson

Dr. James Wilson is a consultant oncologist specialising in lung cancer and advanced radiotherapy. Based in Central London, he works exclusively in private practice, guiding patients swiftly from uncertainty to a clear diagnosis and personalised treatment plan, while providing consistent, practical support when time is critical.